Skip to content

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort - a Prospective, Multicenter Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05862103
Enrollment
15000
Registered
2023-05-17
Start date
2022-12-21
Completion date
2026-12-30
Last updated
2025-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Adverse Event

Keywords

Acute myocardial infarction, Major adverse cardiac and cerebrovascular event, Optimized treatment

Brief summary

AMI Survivors who participated in the project Construction and key technology research of the whole myocardial protection system for acute myocardial infarction (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.

Interventions

AMI emergency treatment process, pre-reperfusion medication, reperfusion strategy selection, and early cardiac rehabilitation after reperfusion

Sponsors

Yu Bo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* AMI survivors who participated in the project Construction and key technology research of the whole myocardial protection system for acute myocardial infarction and completed the 1-year visit. * Telephone to obtain informed consent from the subjects/family members of the subjects.

Exclusion criteria

* Not available

Design outcomes

Primary

MeasureTime frameDescription
Incidence of MACCE5 years after dischargethe incidence of MACCE (death, heart failure, rehospitalization, re-myocardial infarction, re-myocardial revascularization, stroke, malignant arrhythmia, bleeding events, etc.) in AMI patients

Secondary

MeasureTime frameDescription
Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group5 years after dischargeDifferences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group
Differences of MACCE between the optimized group and the non-optimized group5 years after dischargeDifferences of the MACCE between the optimized group and the non-optimized group
Differences of the MACCE between OCT-guided group and the coronary angiography -guided group5 years after dischargeDifferences of the MACCE between OCT-guided group and the coronary angiography -guided group
Differences of MACCE between defer PCI group and direct PCI group3 and 5 years after dischargeDifferences of MACCE between defer PCI group and direct PCI group

Countries

China

Contacts

Primary ContactXiling Zhang, MD
xlzhangdr@163.com+86 13804608748

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026